Optimistic Indian Pharmaceutical Corporations on M&A Road 10 Hours Ago
AstraZeneca’s drug Imfinzi fails as monotherapy for lung cancer 12 hours ago
February 25, 2022
February 25, 2022
November 25, 2022
October 1, 2021
Restart consciousness
The Unsung Hero of Holistic Recovery
Technological disruption in Indian healthcare and pharmaceuticals
Are you ready for the challenge?
Holistic solutions for a healthier India
Adopt dynamic technologies
More than 125,000 industry leaders read it every day
With this acquisition, JB Pharma will complete its cardiac portfolio, becoming a leader in this segment, as Razel ranks among the 10 most sensitive brands in the category of rosuvastatin molecules in the country. These brands in the cardiac segment in India and Nepal with a total market length covered of Rs 2,444 crore.
For the first time since the pandemic began in early 2020, most Americans who die from covid have been at least partially vaccinated, according to new research from federal and state data.